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Background: Since avian-origin H3N2 canine influenza virus (CIV) was first identified in South Korea in 2008, the
novel influenza virus has been reported in several countries in Asia. Reverse zoonotic transmission of pandemic
H1N1 (2009) influenza virus (pH1N1) has been observed in a broad range of animal species. Viral dominance and
characterization of the reassortants of both viruses was undertaken in the present study.
Findings: Here we describe the viral dominance of 23 CIV reassortants between pH1N1 and canine H3N2 influenza
viruses from a naturally co-infected dog. These results indicate that the M gene of pandemic H1N1 and the HA
gene of canine H3N2 are predominant in the reassortants. Furthermore, unlike the original canine H3N2 virus, some
reassortants showed high pathogenicity in mice.
Conclusions: This study suggests that continuous monitoring of influenza infection in companion animals may be
necessary to investigate the potential of the emergence of novel influenza viruses.
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Outbreaks of the infections caused by canine H3N2
(cH3N2) virus of avian origin, which causes severe respira-
tory symptoms in dog populations, have been continuously
reported in South Korea, China, and Thailand since 2007,
and inter–mammalian species transmission (dog to cat) has
also been reported [1–4]. In August 2010, the World
Health Organization announced that pandemic H1N1
(pH1N1) had moved into the post-pandemic period, al-
though localized outbreaks of various magnitudes continue
to occur. In particular, pH1N1 has been transmitted from
humans to several animal species (termed “reverse zoo-
noses”), and many novel reassortant viruses have been
generated [5–9]. Although most cases of reverse zoonoses
have been reported in the pig population, the primary com-
panion animals could be co-infected with pH1N1 and
cH3N2 viruses due to their ecophysiological characteristics* Correspondence: jkfrancis@korea.ac.kr; sds1@korea.ac.kr
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otherwise stated.(synanthropicity). In this study, we isolated 23 distinct viral
genotypes of influenza reassortants by using a nasal swab of
a co-infected dog and characterized the genotypes of the
reassortants.
From 2010 to 2012 in South Korea, we collected 213
nasal swabs from sick dogs showing clinical respiratory
signs and tested the presence of canine influenza virus
(CIV). Mixed infection with cH3N2 and pH1N1 influenza
subtypes was confirmed in an individual dog (a swab speci-
men) using a commercial real-time reverse transcription–
polymerase chain reaction (RT-PCR) kit (SensiFAST™;
Bioline Inc.,Taunton, MA, USA). The real time RT-PCR
targeted specific sequences of HA and NA genes for
pH1N1 or cH3N2 influenza viruses. To determine the un-
identified features, we performed single-plaque purification
assays using the swab, and then the viruses were plaque-
purified in MDCK cells.
Genotyping of plaque-purified viruses were performed as
previously described by Hoffman et al. (2001) with slight
modification [10]. Briefly, one-step RT-PCR (Qiagen) was
conducted using universal primers, and each eight gene;distributed under the terms of the Creative Commons Attribution 4.0
s.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a link
te if changes were made. The Creative Commons Public Domain Dedication
omain/zero/1.0/) applies to the data made available in this article, unless
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merase acidic (PA), hemagglutinin (HA), nucleoprotein
(NP), neuraminidase (NA), matrix (M), and nonstructural
(NS), were sequenced with the amplified and purified gene
segments.
In total 97 different plaques were purified, and then
genotypes of the viruses were established based on the
eight gene segments (PB2, PB1, PA, HA, NP, NA, M,
and NS) that originated from pH1N1 or cH3N2 virus.
The plaques were classified into 23 different genotypic
groups (Table 1). Of the 23 identified genotypic patterns,
three genotypes, namely, VC7 (~33 % of the clones con-
tained the M gene from pH1N1; and the other genes
were from cH3N2), VC78 (~12.4 % of the clones con-
tained the M and NS genes from pH1N1; and the other
genes were from cH3N2, and VC1235678 (~12.4 % of
the clones contained the HA gene from cH3N2; and the
other genes were from pH1N1) were found to be theTable 1 Genetic dominance among the 23 genotypes that
were reassorted with canine H3N2 and pandemic (2009) H1N1
influenza viruses
Genotypea Influenza gene segments No. of
isolates
(%)
PB2 PB1 PA HA NP NA M NS
VC7 C C C C C C P C 32 (32.99)
VC78 C C C C C C P P 12 (12.37)
VC1235678 P P P C P P P P 12 (12.37)
VC235678 C P P C P P P P 6 (6.19)
VC27 C P C C C C P C 5 (5.15)
VCnone C C C C C C C C 4 (4.12)
VC378 C C P C C C P P 4 (4.12)
VC37 C C P C C C P C 3 (3.09)
VC123578 P P P C P C P P 3 (3.09)
VC23578 C P P C P C P P 2 (2.06)
VC678 C C C C C P P P 2 (2.06)
VC12367 P P P C C P P C 1 (1.03)
VC123678 P P P C C P P P 1 (1.03)
VC12378 P P P C C C P P 1 (1.03)
VC125678 P P C C P P P P 1 (1.03)
VC13578 P C P C C C P P 1 (1.03)
VC137 P C P C C C P C 1 (1.03)
VC1378 P C P C C C P P 1 (1.03)
VC237 C P P C C C P C 1 (1.03)
VC3578 C C P C P C P P 1 (1.03)
VC367 C C P C C P P C 1 (1.03)
VC578 C C C C P C P P 1 (1.03)
VC67 C C C C C P P C 1 (1.03)
aInserted gene segments of pH1N1 were labeled as VC#### (e.g., VC37 refers
to the PA(3) and M(7) genes from pH1N1; the other genes are from cH3N2)
C canine H3N2 influenza virus; P pandemic H1N1 influenza virusmost frequently observed among the 97 isolates based
on the plaques. Only four clones (~4.1 %) contained all
eight gene segments of cH3N2 (VCnone), while no clone
containing all gene segments from pH1N1 was detected.
These results indicate that an ecologically significant
yield (93/97; 95.9 %) of the clones could be produced by
recombination between cH3N2 and pH1N1. Addition-
ally, the M and PA genes of pH1N1 were dominant in
the reassortants between the pH1N1 and cH3N2 viruses
(22 and 15 genotypes, respectively). Furthermore, 14 ge-
notypes included the NS gene of pH1N1; ten included
the PB1; nine included the PB2; eight included the NP;
and eight included the NA. However, we did not detect
any genotype pattern that included the HA gene of
pH1N1 (Table 1). Overall, these results indicate that the
M gene of pH1N1 and the HA gene of cH3N2 show
genetic dominance in the reassortants between the
pH1N1 and cH3N2 viruses.Table 2 Viral characteristics of the 23 genotypes in vivo and
in vitro
Genotype Subtype Replicability and pathogenicity
HA titer TCID50/mL EID50/mL MLD50
VC7 H3N2 210 106.6 108.5 n.d.
VC1235678 H3N1 29 105.9 107.25 107.25
VC235678 H3N1 210 105.8 106.5 n.d.
VC78 H3N2 211 106.6 107.5 n.d.
VC123578 H3N2 210 106.8 107.5 104.2
VC678 H3N1 29 106.6 108 n.d.
VC123678 H3N1 210 106.4 107.5 104.9
VC37 H3N2 211 107.8 108 107
VCnone H3N2 210 106.8 106.5 n.d.
VC3578 H3N2 210 106.8 107.5 n.d.
VC12367 H3N1 210 107 107.75 105.5
VC378 H3N2 29 107.5 108 104.25
VC27 H3N2 210 105.8 108 n.d.
VC237 H3N2 210 106.8 107.5 107.26
VC137 H3N2 29 106.8 108.5 n.d.
VC1378 H3N2 29 107.2 108.25 107.75
VC12378 H3N2 210 106.8 107.5 n.d.
VC23578 H3N2 29 106.4 107.25 n.d.
VC125678 H3N1 28 106.2 106.5 104
VC13578 H3N2 29 106.9 107.25 106.85
VC367 H3N1 210 106.6 107.5 n.d.
VC578 H3N2 210 106.6 108.75 n.d.
VC67 H3N1 28 106.9 108.5 n.d.
EID50 50 % egg infectious dose; HA hemagglutinin; MLD50 50 % mouse lethal
dose; n.d. not determined; TCID50 50 % tissue culture infectious dose
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of a representative clone from each group, we determined
HA titers and infectious and lethal doses. HA titers were
measured using chicken red blood cells. The infective dose
was measured using MDCK cells or embryonated chicken
eggs and is presented as the 50 % tissue culture infectious
dose (TCID50) or the 50 % egg infectious dose (EID50).
The lethal dose was determined using mice and is
presented as the 50 % mouse lethal dose (MLD50). The
infective and lethal doses were calculated using the Reed-
Muench method [11]. The clones examined replicated rela-
tively well in mammalian cells and chicken embryos, as
indicated by the HA titers, TCID50, and EID50, which were
within the range of 28–211, 105.8–107.8, and 106.5–108.75,
respectively (Table 2). However, these clones displayed aFig. 1 Body weight changes in mice. Mice (n = 6 per group) were inoculat
daily for 14 days for changes in body weight. Panel a shows body weight
VC78, VC123578, VC678, VC123678, VC37, VCnone, VC3578, VC12367 or VC3
VC137, VC1378, VC12378, VC23578, VC125678, VC13578, VC367, VC578 or VC
day of inoculation (day zero), and the average of each group is shownbroad spectrum of changes in body weight and pathogen-
icity (asymptomatic to severe) in a mouse model (Fig. 1).
For viral pathogenicity in mice, 6-week-old C57BL/6
mice (n = 6 per group) were intranasally inoculated with
106.5 EID50 of virus. Mice were monitored daily for 14 days
for changes in weight and mortality. The experiments con-
ducted in animals were approved by an independent
Animal Care and Use Committee and followed the guide-
lines of the Korea Research Institute of Bioscience and
Biotechnology (Approval number 6015). In particular, mice
infected with VC123578, VC378, or VC125678 showed se-
vere clinical signs and experienced 100 % mortality within
8 days post-inoculation (Fig. 2). The mortality of other
genotypes, namely, VC1235678, VC367, VC12367, VC37,
VC123678, and VC13578 ranged from 17 to 67 %, while noed intranasally with 106.5 EID50 of each virus or PBS and monitored
changes of groups of mice infected with VC7, VC1235678, VC235678,
78. Panel b reveals those of groups of mice infected with VC27, VC237,
67. The changes are represented as the percentage of weight on the
Fig. 2 Survival rates of mice. Mice (n = 6 per group) were inoculated intranasally with 106.5 EID50 of each virus or PBS and monitored daily for 14
days or until death. Panel a shows survival rates of groups of mice infected with VC7, VC1235678, VC235678, VC78, VC123578, VC678, VC123678,
VC37, VCnone, VC3578, VC12367 or VC378. Panel b reveals those of groups of mice infected with VC27, VC237, VC137, VC1378, VC12378, VC23578,
VC125678, VC13578, VC367, VC578 or VC67
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types including the original cH3N2 virus.
The routine surveillance for CIV by my colleagues has
been conducted under the support of Ministry of Health
and Welfare and Ministry of Science, ICT & Future
Planning, Republic of Korea. In the present study, we iso-
lated CIV reassortants from a dog that the co-infection of
pH1N1 and cH3N2 viruses was confirmed through the
surveillance as well as genetic recombination and analyzed
the patterns of genetic recombination between cH3N2
and pH1N1 viruses. Collectively, the M gene of pH1N1
and the HA gene of cH3N2 are responsible for viral dom-
inance, and this tendency was very similar to that reported
in previous studies. For example, Ducatez et al. [6] re-
ported multiple reassortants between pH1N1 and swine
endemic influenza viruses; in particular, of seven distinct
viral genotypes, each included the M gene from pH1N1
and 6, 5, 4, 3, 2, and 1 genotypes included the PA, NS, NP,
PB1, PB2, and HA genes from pH1N1, respectively. Thelimited selection of the HA gene segment from pH1N1
was also consistent with that observed in previous studies
involving the reassortants between pH1N1 and other in-
fluenza viruses [6, 12].
Genomic analysis of plaque-purified clones demon-
strated 23 different genotypes of influenza viruses. All
genotypes showed high infectivity by in vitro inoculation
using MDCK cells or embryonated chicken eggs. How-
ever the genotypes displayed a broad spectrum of patho-
genicity in vivo examination. Because multiple genetic
exchanges had occurred in the clones, it is difficult to
identify the reassortant of one or some gene segments
that play a role in virulence in mice. Upon molecular
analyses for the clones, pathogenicity-related point mu-
tations (e.g., 591R or 591 K within the PB2 protein) were
found in the gene segments from pH1N1 [13], although
other known pathogenicity-related mutations (e.g.,
158G, 627 K, and 701 N within the PB2 protein; 66S
within the PB1 protein; and 97I within the PA protein)
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mutations did not contribute to the differences in the
pathogenicity of the genotypes observed during in vivo
and in vitro examinations.
In our previous study in 2011, it was reported that a
novel H3N1 CIV reassorted with pH1N1 and cH3N2 [8].
The isolate can be categorized under the VC1235678
genotype. Dogs inoculated with H3N1 CIV did not show
notable clinical symptoms, while nasal virus shedding and
mild histopathological lesions were observed following the
experimental inoculation in host animals. Therefore, it
needs to investigate virologic and pathologic examinations
for CIV reassortants of the present study using animal
models in further study.
In most industrialized countries, companion animals are
an integral part of family life, sharing our lifestyles, bed-
rooms, and beds [17]. We had previously shown the possi-
bility of natural reassortment between pH1N1 and cH3N2
in a dog. Thus, these results probably imply that a primary
companion animal, which lives in closer proximity to
humans than do pigs, might act as a mixing vessel or serve
as a source of novel influenza A virus in humans. Further-
more, our findings emphasize that intensive monitoring
for influenza infection in companion animals is necessary
to investigate the potential for the emergence of novel
human influenza strains.
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